Diagnos Inc (TSE:ADK) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Diagnos Inc. has enhanced its board of directors by appointing Michael Braeuel, an entrepreneur with over three decades of business experience and expertise in machine vision inspection technology. The company, recognized for its innovative Artificial Intelligence platform FLAIRE, anticipates Braeuel’s experience will significantly contribute to its growth. Diagnos specializes in early detection of critical health issues, including the use of its AI-driven application CARA for retina analysis.
For further insights into TSE:ADK stock, check out TipRanks’ Stock Analysis page.